Multiple Sclerosis Patients Petition for Better Access to Treatment

Patients with multiple sclerosis have created an online petition to support access to treatment. Join us- the signature collection has begun.

“Patients with multiple sclerosis await funding for treatment! Sign the online petition to help reach out to the Ministry of Health, Tbilisi City Hall and City Council- those who can significantly improve the quality of life of patients. The State should provide funding / co-financing for the treatment and rehabilitation of patients,” reads the statement of patients with Multiple Sclerosis.

The online petition to increase access to treatment has already been developed and the collection of signatures has begun. The purpose of the petition is to provide access to treatment for patients with multiple sclerosis in Georgia. The published results will be sent to the Ministry of Health, Tbilisi City Hall and City Council with a request to support treatment.

www.manifest.ge/main/item/2753?fbclid=IwAR3KeG5ihpnfZUYE0yoMsIvsYzd7nmLxOQ0AKsNsRCh2Svc3ORGnrZlaX_8

There are several medicines for the treatment of multiple sclerosis in Georgia, but they are not funded under any of the ongoing healthcare programs in the country, thus treatment for multiple sclerosis is not available to most patients. It is a shame that patients should become disabled merely because they cannot get the full treatment due to lack of finances.

With timely treatment, they can return to a full-fledged lifestyle in the family and social life and contribute to the country's development.

In support of the patients with multiple sclerosis, a worldwide campaign “Bringing us Closer” has been ongoing since spring. The goal of the campaign is to raise public awareness about the disease, to diagnose it in a timely manner and to provide access to adequate treatment.

Information on Multiple Sclerosis:

Multiple sclerosis is a chronic, progressive neurological disease. Approximately 2.3 million people worldwide have the pathology. The first symptoms mostly appear in the age group of 20 to 40 years; thus multiple sclerosis is a major cause of non-traumatic disability in young people. The disease activity is very important in all forms of the disease - inflammatory processes in the nervous system are followed by the death of neurons in the brain. This process can continue even if the patient has no clinical symptoms. The primary purpose of treatment for multiple sclerosis is to reduce disease activity at an early stage so that disability does not progress. Nowadays, modifying therapy for the treatment of multiple sclerosis is provided that significantly reduces disease activity and the progression of disability.